BSE Live
Feb 06, 16:01Prev. Close
1255.00
Open Price
1255.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 06, 15:50Prev. Close
1259.40
Open Price
1259.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of HALEOS LABS (in Rs. Cr.) | Mar 20 | Mar 19 | |
| Per Share Ratios | |||
| Basic EPS (Rs.) | 33.68 | 59.03 | |
| Diluted EPS (Rs.) | 33.68 | 59.03 | |
| Cash EPS (Rs.) | 59.69 | 80.14 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 382.80 | 351.70 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 382.80 | 351.70 | |
| Revenue from Operations/Share (Rs.) | 862.57 | 1,249.80 | |
| PBDIT/Share (Rs.) | 91.51 | 123.28 | |
| PBIT/Share (Rs.) | 65.51 | 102.18 | |
| PBT/Share (Rs.) | 48.52 | 83.96 | |
| Net Profit/Share (Rs.) | 33.68 | 59.03 | |
| NP After MI And SOA / Share (Rs.) | 33.68 | 59.03 | |
| Profitability Ratios | |||
| PBDIT Margin (%) | 10.60 | 9.86 | |
| PBIT Margin (%) | 7.59 | 8.17 | |
| PBT Margin (%) | 5.62 | 6.71 | |
| Net Profit Margin (%) | 3.90 | 4.72 | |
| NP After MI And SOA Margin (%) | 3.90 | 4.72 | |
| Return on Networth/Equity (%) | 8.79 | 16.78 | |
| Return on Capital Employed (%) | 11.94 | 21.31 | |
| Return on Assets (%) | 4.02 | 6.61 | |
| Total Debt/Equity (X) | 0.50 | 0.38 | |
| Asset Turnover Ratio (%) | 103.14 | 140.05 | |
| Liquidity Ratios | |||
| Current Ratio (X) | 1.23 | 1.14 | |
| Quick Ratio (X) | 0.49 | 0.49 | |
| Inventory Turnover Ratio (X) | 4.06 | 4.66 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 6.60 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 4.86 | |
| Earnings Retention Ratio (%) | 0.00 | 93.40 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 95.14 | |
| Coverage Ratios | |||
| Interest Coverage Ratios (%) | 3.86 | 5.61 | |
| Interest Coverage Ratios (Post Tax) (%) | 3.86 | 5.61 | |
| Valuation Ratios | |||
| Enterprise Value (Cr.) | 102.98 | 204.22 | |
| EV/Net Operating Revenue (X) | 0.39 | 0.54 | |
| EV/EBITDA (X) | 3.72 | 5.48 | |
| MarketCap/Net Operating Revenue (X) | 0.20 | 0.44 | |
| Retention Ratios (%) | 0.00 | 93.39 | |
| Price/BV (X) | 0.46 | 1.57 | |
| Price/Net Operating Revenue | 0.20 | 0.44 | |
| Earnings Yield | 0.19 | 0.11 |
17.11.2025
SMS Lifescience Consolidated September 2025 Net Sales at Rs 81.37 crore, up 3.7% Y-o-Y
12.11.2025
SMS Lifescience Standalone September 2025 Net Sales at Rs 77.84 crore, down 0.83% Y-o-Y
08.09.2025
SMS Lifescience Standalone June 2025 Net Sales at Rs 79.04 crore, down 8.7% Y-o-Y
12.06.2025
SMS Lifescience Standalone March 2025 Net Sales at Rs 85.43 crore, down 1.1% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017